*By Chloe Aiello* CBD is the latest hot trend in wellness ー and Alkaline Water Company is jumping aboard with a new CBD-infused water. "We just see that as a market we can take right onto, and glom onto," Alkaline Water Company CEO Ricky Wright told Cheddar on Tuesday. "We already have a lifestyle health product in \[alkaline water\] ーwe see that as a natural extension." The Alkaline Water Company ($WTER) announced in mid-December it would release hemp-infused, flavored, sparkling, and still waters under the brand "Soothe." Wright said the first bottling plant shipment happened this week, and the company is looking forward to bringing the products to market. CBD is a "natural extension" of current wellness offerings from Alkaline Water Company, Wright said, which is best known for its wellness beverage Alkaline88, a higher pH water. Proponents claim alkaline water can help neutralize acid in the body, although Wright emphasized the company makes no health claims about Alkaline88. He said the company won't make claims about its new CBD products, either ー and thanks to the media, they don't have to. "I think the media is doing a great job letting people know what the benefits, the potential health benefits are. We make no health claims," Wright said, adding that "everybody understands there are some benefits, particularly on the relaxation, particularly on the inflammation." Cannabis industry analysts at [the Brightfield Group projected](https://www.rollingstone.com/culture/culture-news/new-study-cbd-market-22-billion-2022-722852/) the CBD market could balloon to $22 billion by 2022. It's numbers like those that got the Alkaline Water Company very excited. "We just saw the growth. The growth opportunities are tremendous," Wright said. The company was closely watching discussion about [the recently signed Farm Bill](https://cheddar.com/videos/cheddars-crystal-ball-the-2019-outlook-for-cannabis-and-hemp), which contains language that legalizes the cultivation of industrial hemp, or cannabis-derived products with next to no THC. The Farm Bill has left the door cracked open for a legal CBD industry, but Wright acknowledged there are still many obstacles to navigate. "The good news is I've got a couple of great attorneys," Wright joked. More seriously, he said guidance from the Food and Drug Administration has been thin, in part due to the government shutdown. [A statement published Dec. 20](https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm628988.htm), just two days before the shutdown, established a basic outline of how the FDA might navigate the change. "We don't have a lot of guidance there, but we do know they are going to allow us to stay state-to-state. We won't do an interstate commerce type of thing until we get clearance," he said. "Along those lines, we are going for [GRAS ー which is 'generally regarded as safe' ー certification](https://www.fda.gov/Food/IngredientsPackagingLabeling/GRAS/) on our products, so that would allow us to get past some of those other hurdles other companies will have to face." The company plans to launch its Soothe beverages in grocery stores and conveniences stores in Washington and Nevada to start, and move onto other states as they iron out regulatory hurdles. For full interview [click here](https://cheddar.com/videos/alkaline-water-bets-on-cbd-infused-water).

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More